Evolus (EOLS) Payables (2017 - 2026)
Evolus (EOLS) reported Payables of $19.5 million for Q1 2026, up 20.73% on a YoY basis from $16.2 million in Q1 2025, and down 16.4% quarter-over-quarter from $23.4 million in Q4 2025.
Evolus (EOLS) Payables (2017 - 2026) Analysis & Trends
Evolus has reported Payables for 10 years, with the latest figure at $19.5 million in Q1 2026.
- For the quarter ending Q1 2026, Payables rose 20.73% year-over-year to $19.5 million; the trailing twelve-month figure through Mar 2026 stood at $19.5 million (up 20.73% YoY), and the FY2025 full-year result was $23.4 million, up 152.92% from the prior year.
- Payables for Q1 2026 stood at $19.5 million, down from $23.4 million in the prior quarter.
- The five-year high for Payables was $23.4 million in Q4 2025, with the low at $4.3 million in Q4 2023.
- Historically, Payables has averaged $12.9 million across 5 years, with a median of $10.5 million in 2022.
- Annual changes were most pronounced in 2022 — Payables slumped 76.8% — and 2025, when it surged 152.92%.
- Evolus' Payables stood at $8.9 million in 2022, then slumped by 52.2% to $4.3 million in 2023, then soared by 116.25% to $9.2 million in 2024, then surged by 152.92% to $23.4 million in 2025, then declined by 16.4% to $19.5 million in 2026.
- The last three Payables figures came in at $19.5 million (Q1 2026), $23.4 million (Q4 2025), and $23.0 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | 2.60 Bn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 731.00 Mn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 498.30 Mn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | 93.08 Mn |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | 773.00 Mn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | 372.00 Mn |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | 102.36 Mn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 45.88 Mn |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | 306.87 Mn |
| 10 | Evolus | 435.45 Mn | 385.65 Mn | 48.90 Mn | 19.53 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 19.53 Mn |
| Dec 31, 2025 | 23.36 Mn |
| Sep 30, 2025 | 22.96 Mn |
| Jun 30, 2025 | 23.31 Mn |
| Mar 31, 2025 | 16.18 Mn |
| Dec 31, 2024 | 9.24 Mn |
| Sep 30, 2024 | 13.84 Mn |
| Jun 30, 2024 | 10.28 Mn |
| Mar 31, 2024 | 11.22 Mn |
| Dec 31, 2023 | 4.27 Mn |
| Sep 30, 2023 | 11.76 Mn |
| Jun 30, 2023 | 7.84 Mn |
| Mar 31, 2023 | 10.19 Mn |
| Dec 31, 2022 | 8.94 Mn |
| Sep 30, 2022 | 8.56 Mn |
| Jun 30, 2022 | 10.49 Mn |
| Mar 31, 2022 | 7.57 Mn |
| Dec 31, 2021 | 6.09 Mn |
| Sep 30, 2021 | 27.32 Mn |
| Jun 30, 2021 | 27.71 Mn |